Indication-agnostic platform
Built to discover peptide drugs across multiple therapeutic areas.
Peptide drug discovery for muscle and beyond.
Precision oligopeptide discovery platform that combines phenotypic high-throughput screening, built-in target deconvolution, and off-target counterscreens in one workflow applicable to endless targets and indications.
Muscle first
We start with muscle because the unmet need is large, readouts are clear, and the biology is highly actionable.
Powering AI
Our workflow generates structured functional biology data that AI systems can learn from.
WHY IT MATTERS
Muscle is our first wedge into a broader therapeutic platform
Frailty begins as muscle, bone, and joint function decline. Sarcopenia is a strong entry point: high unmet need, clear functional readouts, and no approved drug.
Instead of chasing a single pathway, SageneX maps secretome-inspired oligopeptides across phenotype, receptor context, and mechanism.
OUR PLATFORM
One platform. Multiple therapeutic directions.
Each cycle links peptide libraries, receptor context, functional rescue, mechanism, and early safety signals into one discovery workflow.
→
01
Build peptide libraries
Combinatorial oligopeptide libraries inspired by signaling biology.
→
02
Screen peptide × receptor function
High-throughput screens measure rescue, growth, and functional response.
→
03
Deconvolute mechanism
Built-in target deconvolution maps peptide-receptor-function relationships.
04
Counterscreen and prioritize
Early cardiac and off-target panels prioritize the strongest candidates.
FOCUS AREAS
We discover peptide drugs for muscle and beyond
Muscle is our first focus, with expansion potential across other peptide-responsive biology domains.
TARGET 01Muscle regeneration & hypertrophy
TARGET 02Speed & strength
TARGET 03Energy metabolism
FUTURE
EXPANSION
FUTURE
EXPANSION
Skin
Hair
Brain
Immune
Metabolic
AI-BIO VALUE
Functional biology data that AI-bio labs can use
Our discovery workflow produces structured, mechanism-linked datasets that support internal programs and partnerable AI-bio collaborations.
Human-relevant phenotype data
Structured readouts that reflect function, not just static biomarkers.
Peptide-receptor-function maps
Peptides, receptors, and outcomes connected into actionable maps.
Safety-aware datasets
Counterscreens generate safety-relevant data for candidate prioritization.
Interested in peptide drugs for muscle and beyond?
Reach out for the deck, platform collaborations, or partnership discussions.